BIIB financials
Biogen (BIIB) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
BIIB income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $9.81B | $6.91B | $1.88B | $1.29B | 8.83 |
| 2024 | $9.68B | $7.37B | $2.49B | $1.63B | 11.19 |
| 2023 | $9.84B | $7.30B | $2.10B | $1.16B | 7.97 |
| 2022 | $10.17B | $7.90B | $2.89B | $3.05B | 20.87 |
| 2021 | $10.98B | $8.87B | $2.79B | $1.56B | 10.40 |
| 2020 | $13.44B | $11.64B | $4.59B | $4.00B | 24.80 |
- BIIB revenue was $9.81B in fiscal 2025, net income $1.29B.
Updated 2026-11-02 23:14 UTC